Asia Pacific Pharma Sector Analysis

The report, “Asia Pacific Pharma Sector Analysis”, finds that the market growth will mainly be driven by factors, like changing regulatory environment, increasing disposable incomes, rising prevalence of lifestyle diseases, and significant developments in the field of contract manufacturing, particularly in APIs. On studying the pharmaceutical market in each country, we observed that mature markets such as Japan and Australia are experiencing slower growth rates, while emerging as new market leaders, China and India are enjoying investments by foreign pharmaceutical companies. South Korea and New Zealand are relatively small markets, with the growth limited by the size of these island nations. We have also studied the market scenario in Indonesia, Thailand, the Philippines, Malaysia and Vietnam.

We also found out why the Asia-Pacific region is emerging as a new destination for the generic drugs industry. As per our findings, the western countries face the issue of poorly defined regulatory pathways, and a few Asian countries are well positioned to benefit from these changes, attracting huge investments by generic companies. The OTC sector in the region has also been expanding rapidly. The study of other emerging trends revealed that the growing market for vaccines and medical tourism is giving new dimension to the region’s pharmaceutical industry. Though Asia-Pacific is emerging as a right place for the drug-related research, the region lacks IPR regime. The report provides in-depth information about regulatory environment and key market players in each country. This way, our research work aims at presenting a fair picture of the industry to clients.

1. Analyst View 2. Research Methodology 3. Global Pharmaceutical Market Overview 3.1 Leading Drugs in Global Pharma Market 4. Asia-Pacific Pharmaceutical Market Scenario 5. Country-level Analysis: Studying the Future Market 5.1 China 5.1.1 Market Overview 5.1.2 Regulatory Environment 5.1.3 Key Players 5.2 India 5.2.1 Market Overview 5.2.2 Regulatory Environment 5.2.3 Key Players 5.3 Japan 5.3.1 Market Overview 5.3.2 Regulatory Environment 5.3.3 Key Players 5.4 South Korea 5.4.1 Market Overview 5.4.2 Regulatory Environment 5.4.3 Key Players 5.5 Indonesia 5.5.1 Market Overview 5.5.2 Regulatory Environment 5.5.3 Key Players 5.6 Vietnam 5.6.1 Market Overview 5.6.2 Regulatory Environment 5.6.3 Key Players 5.7 Thailand 5.7.1 Market Overview 5.7.2 Regulatory Environment 5.7.3 Key Players 5.8 Philippines 5.8.1 Market Overview 5.8.2 Regulatory Environment 5.8.3 Key Players 5.9 Malaysia 5.9.1 Market Overview 5.9.2 Regulatory Environment 5.9.3 Key Players 5.10 Australia 5.10.1 Market Overview 5.10.2 Regulatory Environment 5.10.3 Key Players 5.11 New Zealand 5.11.1 Market Overview 5.11.2 Regulatory Environment 5.11.3 Key Players 6. Emerging Market Trends 6.1 Growing CRO Market 6.2 Rising Development of New Vaccines 6.3 Increasing Demand of Generic Drugs 6.4 Booming Medical Tourism Market

List of Figures:

Figure 3-1: Global - Pharmaceutical Market (Billion US$), 2010-2015 Figure 3-2: Global - Breakup of Pharmaceutical Market by Region (%), 2010 Figure 4-1: Asia-Pacific - Pharmaceutical Market (Billion US$), 2010-2015 Figure 4-2: Asia-Pacific - Pharmaceutical Market by Country (%), 2011 Figure 4-3: Asia-Pacific - Forecast for Pharmaceutical Market by Country (%), 2015 Figure 5-1: China - Pharmaceutical Market (Billion US$), 2010-2015 Figure 5-2: China - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2010) Figure 5-3: China - Share of Generic Drugs in Pharma Market (2011) Figure 5-4: China - Share of OTC and Prescription Drugs in Pharma Market (2011) Figure 5-5: China - Pharmaceutical Exports and Imports (Billion US$), 2009 & 2010 Figure 5-6: India - Pharmaceutical Market (Billion US$), FY 2010-FY 2015 Figure 5-7: India - Share of Imported and Domestically Manufactured Drugs in Pharma Market (FY 2011) Figure 5-8: India - Share of Generics and Branded Drugs in Pharma Market (2011) Figure 5-9: India - Share of OTC and Prescription Drugs in Pharma Market (2011) Figure 5-10: India - Pharmaceutical Exports and Imports (Billion US$), FY 2009 & FY 2010 Figure 5-11: Japan - Pharmaceutical Market (Billion US$), 2010-2015 Figure 5-12: Japan - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2010) Figure 5-13: Japan - Share of Generics and Branded Drugs in Pharma Market (2011) Figure 5-14: Japan - Share of OTC and Prescription Drugs in Pharma Market (2011) For more information kindly visit : Asia Pacific Pharma Sector Analysis

Or

Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Fax: + 91 22 27812290 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: http://twitter.com/#!/Sandhya3B Our Blogs: http://twitter.com/#!/bharatbook http://agriculturemarketreports.blogspot.in/

Related Articles - health reports, pharmaceuticals, market data, market research reports.,

Email this Article to a Friend! Receive Articles like this one direct to your email box! Subscribe for free today!